Zecotek Photonics announced that the National Cancer Institute has released positive results of the test conducted on Zecotek’s tunable green fiber laser. Bethesda-based National Cancer Institute Flow Cytometry Core Laboratory’s Director, Dr. William Telford, showed the test results at CYTO (Congress for the International Advancement of Cytometry) in Seattle.
Dr. Telford informed that the tunable green fiber laser offers superior detection resolution and reduced noise over the range of 540-550 nm. The tunable laser increases the analytical capability and enhances the data collection process, Dr. Telford said.
Zecotek’s CEO and President, Dr. A.F. Zerrouk, stated that the test results demonstrate that the green fiber laser surpasses other conventional lasers and contributes immensely in the advancement of bioinstrumentation. He also added that Dr. Telford’s observations on the merits of the tunable lasers for flow cytometry application support their efforts to bring the unique laser technology into the market.
Dr. Telford emphasized that Zecotek’s fixed and tunable wavelength fiber lasers are suitable for a number of applications such as organ transplantation, hematology, immunology and biomedical research, among others. The tunable lasers also offer new models of flourochromes for research and analysis, he informed.